Related Experiment Video

Updated: Mar 26, 2026

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

11.9K

αB-crystallin: Portrait of a malignant chaperone as a cancer therapeutic target

Dmitry Malin1, Vladimir Petrovic1, Elena Strekalova1

  • 1Department of Medicine, University of Wisconsin Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Pharmacology & Therapeutics
|January 29, 2016
PubMed

Insights

Alpha B-crystallin (αB-crystallin), a small heat shock protein, protects cells from stress and inhibits apoptosis. Its dysregulation in tumors promotes progression and metastasis, suggesting it as a therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cellular Stress Response

Background:

  • Alpha B-crystallin (αB-crystallin) is a small heat shock protein with cytoprotective roles.
  • It functions as a molecular chaperone and an antagonist of apoptosis.
  • Aberrant αB-crystallin expression is observed in various solid tumors, correlating with poor prognosis.

Purpose of the Study:

  • To review novel mechanisms of αB-crystallin deregulation by tumor microenvironmental factors.
  • To summarize the role of αB-crystallin in cancer metastasis.
  • To discuss emerging therapeutic strategies targeting αB-crystallin.

Main Methods:

  • Literature review focusing on molecular mechanisms and clinical implications.
  • Analysis of studies investigating oncogene, oxidative stress, and matrix detachment effects.
  • Evaluation of preclinical and clinical data on αB-crystallin-targeted therapies.

Main Results:

  • Tumor microenvironmental stressors like oncogenes and matrix detachment deregulate αB-crystallin expression.
  • αB-crystallin is crucial for cancer cell migration, survival, and colonization during metastasis.
  • Targeting αB-crystallin shows potential in activating apoptosis and inhibiting metastasis.

Conclusions:

  • Deregulated αB-crystallin is a key driver of tumor progression and metastasis.
  • Therapeutic strategies targeting αB-crystallin offer a promising approach to combat metastatic disease.
  • Further research is warranted to develop effective αB-crystallin-based cancer therapies.
Keywords:
ApoptosisCancerDrug targetMetastasisMolecular chaperoneStress response

More Related Videos

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.5K
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

6.0K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K